OBJECTIVES: To describe the rate of progression to AIDS and survival following AIDS diagnosis in HIV-infected Africans living in London. To identify factors influencing progression and outcome of disease. DESIGN: Retrospectively constructed prevalent cohort. SETTING: Outpatient clinic population, London. SUBJECTS: HIV-infected individuals of African origin presenting between January 1986 and October 1994. MAIN OUTCOME MEASURES: AIDS indicator illness; cumulative survival probabilities to AIDS diagnosis and from AIDS diagnosis to death; rate of progression to AIDS. RESULTS: Ninety six patients (57 women) provided 166 person years of follow up. Median CD4 lymphocyte count at presentation was 205 (90% range 20-577) x 10(6)/l. Kaplan-Meier estimates of the proportion (95% confidence interval) of patients developing AIDS from the time of enrollment were 18 (9 to 27)% at 12 months and 44 (30 to 58)% at 36 months. Only CD4 count at HIV diagnosis was independently associated with a faster rate of progression to AIDS (adjusted relative hazard 9.18%, 95% confidence interval 2.84 to 29.67, p < 0.001). The proportion (95% confidence interval) surviving following AIDS diagnosis was estimated to be 73 (55 to 91)% at 12 months and 25 (0 to 52)% at 36 months. CONCLUSIONS: HIV-infected people of sub-Saharan African origin living in London present with advanced disease. When compared with published studies, their survival experience is comparable to that observed in HIV-infected individuals born in developed countries.
OBJECTIVES: To describe the rate of progression to AIDS and survival following AIDS diagnosis in HIV-infected Africans living in London. To identify factors influencing progression and outcome of disease. DESIGN: Retrospectively constructed prevalent cohort. SETTING:Outpatient clinic population, London. SUBJECTS:HIV-infected individuals of African origin presenting between January 1986 and October 1994. MAIN OUTCOME MEASURES: AIDS indicator illness; cumulative survival probabilities to AIDS diagnosis and from AIDS diagnosis to death; rate of progression to AIDS. RESULTS: Ninety six patients (57 women) provided 166 person years of follow up. Median CD4 lymphocyte count at presentation was 205 (90% range 20-577) x 10(6)/l. Kaplan-Meier estimates of the proportion (95% confidence interval) of patients developing AIDS from the time of enrollment were 18 (9 to 27)% at 12 months and 44 (30 to 58)% at 36 months. Only CD4 count at HIV diagnosis was independently associated with a faster rate of progression to AIDS (adjusted relative hazard 9.18%, 95% confidence interval 2.84 to 29.67, p < 0.001). The proportion (95% confidence interval) surviving following AIDS diagnosis was estimated to be 73 (55 to 91)% at 12 months and 25 (0 to 52)% at 36 months. CONCLUSIONS:HIV-infectedpeople of sub-Saharan African origin living in London present with advanced disease. When compared with published studies, their survival experience is comparable to that observed in HIV-infected individuals born in developed countries.
Authors: B N'Galy; R W Ryder; K Bila; K Mwandagalirwa; R L Colebunders; H Francis; J M Mann; T C Quinn Journal: N Engl J Med Date: 1988-10-27 Impact factor: 91.245
Authors: S K Hira; N Ngandu; D Wadhawan; B Nkowne; K S Baboo; R Macuacua; J Kamanga; B Mpoko; I M Heiba; P L Perine Journal: J Acquir Immune Defic Syndr (1988) Date: 1990
Authors: C P Lindan; S Allen; A Serufilira; A R Lifson; P Van de Perre; A Chen-Rundle; J Batungwanayo; F Nsengumuremyi; J Bogaerts; S Hulley Journal: Ann Intern Med Date: 1992-02-15 Impact factor: 25.391
Authors: S B Lucas; A Hounnou; C Peacock; A Beaumel; G Djomand; J M N'Gbichi; K Yeboue; M Hondé; M Diomande; C Giordano Journal: AIDS Date: 1993-12 Impact factor: 4.177
Authors: Lin Chen; Jiezhe Yang; Renjie Zhang; Yun Xu; Jinlei Zheng; Jianmin Jiang; Jun Jiang; Lin He; Ning Wang; Philip Chun Yeung; Xiaohong Pan Journal: AIDS Res Ther Date: 2015-09-25 Impact factor: 2.250